ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 2888

$2.62M Total Retail Price of All Prescriptions

Rank: 10 out of 2888

715 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

27% of this provider’s 715 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 15,546 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$137 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,048 492 S3 1 4
CRESTOR 712 613 2 20
AMLODIPINE BESYLATE 689 586 3 5
SIMVASTATIN 507 406 4 2
NEXIUM 485 433 5 19
TRAMADOL HCL 434 386 6 16
ZOLPIDEM TARTRATE 416 284 7 17
ATORVASTATIN CALCIUM 358 310 8 9
LOSARTAN POTASSIUM 350 281 9 18
METOPROLOL SUCCINATE 300 266 10 11
LEVOFLOXACIN 277 221 11 57
NASONEX 262 217 12 168
GABAPENTIN 247 175 13 13
CARVEDILOL 244 176 14 21
IBUPROFEN 242 169 15 87
METFORMIN HCL 233 213 16 8
OMEPRAZOLE 233 159 16 7
LOSARTAN-HYDROCHLOROTHIAZIDE 230 171 18 46
LISINOPRIL 227 158 19 3
LOVAZA 225 202 20 97
TAMSULOSIN HCL 224 213 21 29
ATELVIA 223 217 22 201
ALENDRONATE SODIUM 206 180 23 23
AZITHROMYCIN 197 164 24 38
MOMETASONE FUROATE 194 174 25 268
LIDODERM 193 172 26 105
GLYBURIDE-METFORMIN HCL 191 147 R 27 64
LEVOTHYROXINE SODIUM 190 157 28 1
FUROSEMIDE 185 152 29 6
BYSTOLIC 172 159 30 99
MELOXICAM 170 143 31 31
LANSOPRAZOLE 163 125 32 213
ACTOS 161 149 33 108
VOLTAREN 161 151 33 157
CYCLOBENZAPRINE HCL 158 57 R 35 68
DIOVAN HCT 154 142 36 61
BENICAR 144 143 37 138
CELEBREX 142 112 38 89
BENICAR HCT 134 120 39 181
ADVAIR DISKUS 133 118 40 60
FENOFIBRATE 130 107 41 65
CLOPIDOGREL 130 109 41 30
TRICOR 127 117 43 91
LIPITOR 126 113 44 78
LYRICA 123 112 45 69
JANUVIA 123 112 45 48
DONEPEZIL HCL 120 113 47 26
DICLOFENAC SODIUM 120 73 47 141
BETAMETHASONE DIPROPIONATE 118 103 49 314
AVODART 113 107 50 151
FLUTICASONE PROPIONATE 111 98 51 32
POTASSIUM CHLORIDE 110 87 52 14
HYDROCHLOROTHIAZIDE 109 75 53 15
IBANDRONATE SODIUM 108 108 54 272
MEGACE ES 108 104 R 54 310
FAMOTIDINE 106 91 56 75
SPIRIVA 105 91 57 79
PATADAY 104 102 58 261
PLAVIX 103 89 59 40
GLIMEPIRIDE 102 99 60 36
NAMENDA 102 102 60 34
TRIAMCINOLONE ACETONIDE 96 87 62 145
DIOVAN 96 90 62 35
CARISOPRODOL 89 16 R 64 82
PROAIR HFA 88 57 65 71
SINGULAIR 87 70 66 85
BONIVA 87 86 66 319
NAPROXEN 87 63 66 80
CIPROFLOXACIN HCL 86 66 69 47
HYDROXYZINE HCL 83 71 R 70 174
MECLIZINE HCL 81 78 71 122
SYMBICORT 78 41 72 142
VESICARE 75 73 73 154
MEGESTROL ACETATE 74 74 R 74 140
PIOGLITAZONE HCL 72 65 R 75 248
ENABLEX 71 62 76 269
PANTOPRAZOLE SODIUM 68 64 77 33
ACTONEL 67 67 78 149
FORTEO 66 66 79 292
AMLODIPINE BESYLATE-BENAZEPRIL 64 61 80 67
COREG CR 61 58 81 432
AMITRIPTYLINE HCL 61 43 R 81 74
DEXILANT 60 53 83 186
CLONIDINE HCL 59 32 84 39
PREDNISONE 59 44 84 42
JANUMET 59 52 84 131
PRAVASTATIN SODIUM 58 43 87 12
COLCRYS 57 50 88 295
EVISTA 57 57 88 125
FINASTERIDE 55 55 90 102
BARACLUDE 51 38 91 483
ATENOLOL 51 40 91 25
NIFEDIPINE ER 50 47 93 76
LACTULOSE 50 39 93 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.